NASDAQ : IRLA
Quince Therapeutics, Inc. — Financial statements
United States
Last price 31.62 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 32.16M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 27.81M | 15.05M | 17.58M | 15.39M | 24.91M | 29.52M |
| Research & Development | 32.99M | 35.38M | 18.59M | 9.25M | 25.18M | 60.80M |
| Operating Expenses | 60.80M | 50.43M | 36.17M | 24.64M | 50.09M | 90.32M |
| Operating Income | -60.80M | -50.43M | -36.17M | -24.64M | -50.09M | -90.32M |
| Interest & Investment Income | 1.27M | 1.24M | 2.93M | 3.48M | 1.07M | 620.00K |
| Currency Exchange Gain (Loss) | 486.00K | 486.00K | -676.00K | 1.00K | -767.00K | -247.00K |
| Other Non Operating Income (Expenses) | 19.69M | -22.38M | ||||
| EBT Excluding Unusual Items | -39.35M | -71.08M | -33.92M | -21.16M | -49.79M | -89.94M |
| Merger & Restructuring Charges | -2.50M | -1.10M | ||||
| Impairment of Goodwill | -17.13M | -825.00K | ||||
| Gain (Loss) on Sale of Assets | -37.00K | -94.00K | ||||
| Asset Writedown | -67.81M | -5.97M | -136.00K | |||
| Other Unusual Items | 71.52M | -9.68M | -5.69M | -1.92M | ||
| Pretax Income | -94.64M | -80.77M | -56.74M | -31.58M | -51.94M | -89.94M |
| Income Tax Expense | -2.16M | 3.21M | 87.00K | -197.00K | -284.00K | |
| Net Income | -92.48M | -83.98M | -56.83M | -31.39M | -51.66M | -89.94M |
| Net Income to Common | -92.48M | -83.98M | -56.83M | -31.39M | -51.66M | -89.94M |
| Shares Outstanding (Basic) | 1.79M | 250.48K | 216.31K | 186.19K | 167.48K | 148.59K |
| Shares Outstanding (Diluted) | 1.79M | 250.48K | 216.31K | 186.19K | 167.48K | 148.59K |
| EPS (Basic) | -51.81 | -335.27 | -262.71 | -168.57 | -308.45 | -605.31 |
| EPS (Diluted) | -51.81 | -335.27 | -262.71 | -168.57 | -308.45 | -605.31 |
| Free Cash Flow | -47.00M | -41.78M | -32.16M | -18.45M | -44.17M | -63.11M |
| Free Cash Flow Per Share | -26.33 | -166.78 | -148.68 | -99.11 | -263.73 | -424.73 |
| EBITDA | -60.65M | -50.29M | -35.98M | -24.32M | -49.89M | -89.97M |
| D&A For EBITDA | 152.00K | 142.00K | 186.00K | 322.00K | 204.00K | 344.00K |
| EBIT | -60.80M | -50.43M | -36.17M | -24.64M | -50.09M | -90.32M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 115.98M | 5.81M | 6.21M | 20.75M | 44.58M | 69.72M |
| Short-Term Investments | 11.94M | 34.57M | 54.31M | 45.60M | 37.08M | |
| Cash & Short-Term Investments | 115.98M | 17.75M | 40.78M | 75.06M | 90.18M | 106.80M |
| Other Receivables | 5.00M | 3.62M | 882.00K | 993.00K | 1.00M | 1.13M |
| Receivables | 5.00M | 3.62M | 882.00K | 993.00K | 1.00M | 1.13M |
| Prepaid Expenses | 766.00K | 890.00K | 986.00K | 1.17M | 1.20M | 1.48M |
| Other Current Assets | 1.66M | 632.00K | 1.38M | 214.00K | 1.36M | 2.27M |
| Total Current Assets | 123.41M | 22.90M | 44.04M | 77.44M | 93.75M | 111.67M |
| Property, Plant & Equipment | 506.00K | 1.05M | 813.00K | 619.00K | 684.00K | 1.43M |
| Long-Term Investments | 78.00K | 78.00K | 78.00K | 78.00K | 3.58M | 19.93M |
| Goodwill | 17.62M | |||||
| Other Intangible Assets | 67.82M | 60.05M | 63.67M | 5.90M | ||
| Other Long-Term Assets | 1.68M | 9.51M | 8.47M | 194.00K | ||
| Total Assets | 124.00M | 93.52M | 114.48M | 167.90M | 103.91M | 133.23M |
| Accounts Payable | 4.64M | 2.22M | 2.90M | 2.03M | 570.00K | 4.91M |
| Accrued Expenses | 3.50M | 10.29M | 3.97M | 3.12M | 1.86M | 8.39M |
| Current Portion of Long-Term Debt | 18.03M | |||||
| Current Portion of Leases | 115.00K | 96.00K | 64.00K | 453.00K | 741.00K | |
| Other Current Liabilities | 364.00K | 12.58M | 308.00K | 4.36M | 185.00K | 180.00K |
| Total Current Liabilities | 8.50M | 43.23M | 7.28M | 9.57M | 3.07M | 14.22M |
| Long-Term Debt | 14.32M | 13.43M | ||||
| Long-Term Leases | 330.00K | 394.00K | 321.00K | 420.00K | ||
| Long-Term Deferred Tax Liabilities | 4.96M | 5.30M | 248.00K | |||
| Other Long-Term Liabilities | 7.01M | 85.68M | 57.38M | 54.19M | ||
| Total Liabilities | 15.51M | 129.24M | 84.33M | 82.82M | 3.32M | 14.64M |
| Common Stock | 1.00K | 55.00K | 44.00K | 43.00K | 36.00K | 30.00K |
| Additional Paid-In Capital | 460.45M | 418.93M | 406.61M | 401.64M | 389.11M | 355.23M |
| Retained Earnings | -500.03M | -460.45M | -376.47M | -319.64M | -288.26M | -236.60M |
| Comprehensive Income & Other | 4.25M | 5.75M | -35.00K | 3.05M | -289.00K | -79.00K |
| Total Common Equity | -35.32M | -35.71M | 30.15M | 85.08M | 100.59M | 118.59M |
| Shareholders' Equity | 108.49M | -35.71M | 30.15M | 85.08M | 100.59M | 118.59M |
| Total Liabilities & Equity | 124.00M | 93.52M | 114.48M | 167.90M | 103.91M | 133.23M |
| Total Debt | 18.47M | 14.81M | 13.81M | 453.00K | 1.16M | |
| Net Cash (Debt) | 115.98M | -719.00K | 25.97M | 61.24M | 89.73M | 105.64M |
| Net Cash Per Share | 64.97 | -2.87 | 120.07 | 328.95 | 535.74 | 710.94 |
| Filing Date Shares Outstanding | 1.02M | 815.04K | 220.01K | 216.08K | 181.38K | 150.73K |
| Total Common Shares Outstanding | 1.02M | 278.63K | 220.01K | 214.87K | 180.68K | 150.37K |
| Working Capital | 114.91M | -20.33M | 36.76M | 67.87M | 90.68M | 97.45M |
| Book Value Per Share | -34.73 | -128.18 | 137.02 | 395.99 | 556.74 | 788.62 |
| Tangible Book Value | -35.32M | -103.53M | -29.90M | 3.79M | 94.69M | 118.59M |
| Tangible Book Value Per Share | -34.73 | -371.58 | -135.90 | 17.62 | 524.09 | 788.62 |
| Machinery | 1.31M | 1.37M | 892.00K | 675.00K | 433.00K | 607.00K |
| Leasehold Improvements | 37.00K | 38.00K | 34.00K | 36.00K | 21.00K | 58.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -92.48M | -83.98M | -56.83M | -31.39M | -51.66M | -89.94M |
| Depreciation & Amortization | 152.00K | 142.00K | 186.00K | 322.00K | 204.00K | 344.00K |
| Loss (Gain) From Sale of Assets | -41.00K | 94.00K | ||||
| Asset Writedown & Restructuring Costs | 126.81M | 17.13M | 5.97M | 961.00K | ||
| Loss (Gain) From Sale of Investments | -486.00K | -1.01M | -2.35M | -2.02M | -113.00K | 878.00K |
| Stock-Based Compensation | 15.82M | 5.11M | 4.75M | 5.22M | 16.62M | 29.85M |
| Other Operating Activities | -99.44M | 25.48M | 5.69M | 1.67M | -313.00K | 199.00K |
| Change in Accounts Payable | 6.65M | -940.00K | 927.00K | -288.00K | -5.94M | 1.36M |
| Change in Other Net Operating Assets | -3.95M | 13.78M | -1.41M | 2.27M | -3.89M | -5.62M |
| Operating Cash Flow | -46.92M | -41.42M | -31.90M | -18.29M | -44.04M | -62.93M |
| Capital Expenditures | -78.00K | -352.00K | -257.00K | -160.00K | -133.00K | -180.00K |
| Sale of Property, Plant & Equipment | 90.00K | 70.00K | ||||
| Cash Acquisitions | 8.00M | -2.12M | 10.59M | |||
| Investment in Securities | 18.37M | 23.58M | 22.16M | -2.57M | 7.47M | 59.13M |
| Other Investing Activities | -1.00M | |||||
| Investing Cash Flow | 26.29M | 23.23M | 21.91M | -5.76M | 18.00M | 58.95M |
| Long-Term Debt Repaid | -6.00K | -49.00K | ||||
| Net Debt Issued (Repaid) | -5.54M | -6.00K | -49.00K | |||
| Issuance of Common Stock | 23.75M | 17.91M | 225.00K | 149.00K | 756.00K | 6.81M |
| Other Financing Activities | -56.00K | -5.00M | ||||
| Financing Cash Flow | 121.79M | 17.91M | -4.78M | 143.00K | 707.00K | 6.81M |
| Foreign Exchange Rate Adjustments | -2.00M | -114.00K | 231.00K | 80.00K | 184.00K | 55.00K |
| Net Cash Flow | 99.16M | -403.00K | -14.54M | -23.83M | -25.14M | 2.88M |
| Free Cash Flow | -47.00M | -41.78M | -32.16M | -18.45M | -44.17M | -63.11M |
| Free Cash Flow Per Share | -26.33 | -166.78 | -148.68 | -99.11 | -263.73 | -424.73 |
| Levered Free Cash Flow | -25.75M | -10.61M | -21.13M | -1.94M | -24.18M | -30.54M |
| Unlevered Free Cash Flow | -25.75M | -10.61M | -21.13M | -1.94M | -24.18M | -30.54M |
| Cash Interest Paid | 146.00K | 234.00K | ||||
| Change in Working Capital | 2.70M | 12.84M | -484.00K | 1.98M | -9.83M | -4.26M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 34.12M | 186.53M | 82.28M | 45.01M | 23.03M | 377.06M |
| Enterprise Value | -81.86M | 178.24M | 49.89M | -38.15M | -70.89M | 263.99M |
| Last Close Price | 33.55 | 670.00 | 374.00 | 210.00 | 127.48 | 2,524.00 |
| PB Ratio | 0.31 | -5.22 | 2.73 | 0.53 | 0.23 | 3.18 |
| P/TBV Ratio | 11.89 | 0.24 | 3.18 | |||
| Debt / Equity Ratio | -0.52 | 0.49 | 0.16 | 0.01 | 0.01 | |
| Net Debt / Equity Ratio | -1.07 | -0.02 | -0.86 | -0.72 | -0.89 | -0.89 |
| Net Debt / EBITDA Ratio | 1.91 | -0.01 | 0.72 | 2.52 | 1.80 | 1.17 |
| Net Debt / FCF Ratio | 2.47 | -0.02 | 0.81 | 3.32 | 2.03 | 1.67 |
| Quick Ratio | 14.23 | 0.49 | 5.72 | 7.95 | 29.71 | 7.59 |
| Current Ratio | 14.52 | 0.53 | 6.05 | 8.09 | 30.55 | 7.85 |
| Return on Equity (ROE) | -153.84% | -98.63% | -33.81% | -47.14% | -61.85% | |
| Return on Assets (ROA) | -31.51% | -30.31% | -16.01% | -11.33% | -26.40% | -34.99% |
| Return on Capital Employed (ROCE) | -52.60% | -100.30% | -33.70% | -15.60% | -49.70% | -75.90% |
| Earnings Yield | -154.41% | -45.02% | -69.06% | -69.73% | -224.32% | -23.86% |
| FCF Yield | -137.74% | -22.40% | -39.09% | -40.99% | -191.80% | -16.74% |
| Buyback Yield / Dilution | -704.22% | -15.80% | -16.18% | -11.17% | -12.71% | -1.86% |